March 11, 2024 · Form 4 insider transaction
Levitz Michael L bought 5,875 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Reflects the first vesting installment of RSUs granted on March 9, 2023.